Mag-aso, Mia Jane .

HRN: 18-98-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CO-AMOXICLAV 625MG (TAB)
07/01/2026
07/07/2026
ORAL
625mg
BID
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: